Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
BYS's total shareholding is not sufficient to be the boss yet :) Let's see whether BYS will cont to accumulate post qr. No idea what is driving the interest of BYS on Plabs.
Thanks to Plabs for the interim dividend. Did not expect it :) On top of the dividend, shareholders would have noticed two more major activities in the report under notes A10 pg 8 - additions of industrial land and construction of 1 block of factory :)
Nice average you have there, Time and Space. Judging from Mr Bu's acquisitions/announcements, his bulk of purchase could be near to 0.195+/-0.005. Hence, prices at this range with volume would have been swept away by Mr. Bu.
I have no idea, Warrenky. He knows something that we don't know. I saw notes on industrial land acquisition and construction of 1 factory in the Plabs report. Sounded like expansion.
Perhaps Mr. Bu is eyeing the expansion plan for its manufacturing and trading business. Extracted these from the latest annual report - In December 2023, Osmosis has commenced construction an additional one block factory to cater for Osmofat production in Nilai. And recent land acquisition is to facilitate a seamless expansion of its trading business in the near future.
That's a good question and a tough one, T&S. Nothing mentioned about it. However, if you have been following the manufacturing segment, you will noticed that FY2023 revenue at 5.4M is the highest by far that I can recalled; at least over the last 5 years. Used to be hovering around plus minus 3M to less than 5M; FY2022 was at 2.8M. Additionally, you will also noticed that there are new markets added as part of risk mitigation for epidemics over the last two years - China, Egypt, and Belarus. Barring any unforeseen circumstances, the manufacturing segment should be seeing growth again - new markets and available capacity :)
